Metabolism of green tea catechins: an overview
- PMID: 17073579
- DOI: 10.2174/138920006778520552
Metabolism of green tea catechins: an overview
Abstract
Green tea is one of the most popular beverages worldwide. Its major components include (-)-epicatechin ((-)-EC), (-)-epicatechin-3-gallate (ECG) (-)-epigallocatechin (EGC) and (-)-epigallocatechin-3-gallate (EGCG). It has demonstrated strong antioxidative, anti-inflammatory and anti-cancerous properties and attracted a great deal of interest over last several years. However, there is some discrepancy between the results from human pidemiological studies and cultured cell and animal models. Two reasons for its limited in vivo activities have been considered: metabolism and bioavailability. Recent studies have demonstrated that green tea catechins undergo methylation, glucuronidation and sulfation in in vitro systems and in animals and in humans. It has been also found that efflux transporters Pgp, MRP1 and MRP2 play roles in the absorption and excretion of green tea catechins. Several processes including intestinal metabolism, microbial metabolism, hepatic metabolism and chemical degradation have been found to be involved in the fate of green tea, and to be responsible for its low availability in animals, and most likely also in humans. Pharmacokinetics, absorption, distribution, drug metabolism and excretion properties of green tea provide a better understanding for its in vivo activities. In this article, drug metabolism and microbial metabolism of green tea catechins in in vitro systems and in animals and in humans will be reviewed. It also covers the factors affecting their biotransformation and bioavailability: drug-drug inhibitory and inductive interactions of phase I and phase II enzymes, inhibition of non-drug-metabolizing enzymes, transporters, chemical instability, epimerization and interindividual variability.
Similar articles
-
An Appraisal of Drug-Drug Interactions with Green Tea (Camellia sinensis).Planta Med. 2017 Apr;83(6):496-508. doi: 10.1055/s-0043-100934. Epub 2017 Jan 24. Planta Med. 2017. PMID: 28118673 Review.
-
The challenge of developing green tea polyphenols as therapeutic agents.Inflammopharmacology. 2008 Oct;16(5):248-52. doi: 10.1007/s10787-008-8031-x. Inflammopharmacology. 2008. PMID: 18815735 Free PMC article. Review.
-
Absorption and pharmacokinetics of green tea catechins in beagles.Br J Nutr. 2008 Sep;100(3):496-502. doi: 10.1017/S0007114507898692. Epub 2008 Jan 21. Br J Nutr. 2008. PMID: 18205995
-
Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of Polyphenon E in healthy individuals.Clin Cancer Res. 2005 Jun 15;11(12):4627-33. doi: 10.1158/1078-0432.CCR-04-2549. Clin Cancer Res. 2005. PMID: 15958649 Clinical Trial.
-
Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability.Cancer Epidemiol Biomarkers Prev. 2002 Oct;11(10 Pt 1):1025-32. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 12376503
Cited by
-
Alzheimer's Disease and Green Tea: Epigallocatechin-3-Gallate as a Modulator of Inflammation and Oxidative Stress.Antioxidants (Basel). 2023 Jul 20;12(7):1460. doi: 10.3390/antiox12071460. Antioxidants (Basel). 2023. PMID: 37507998 Free PMC article. Review.
-
Catechins: Protective mechanism of antioxidant stress in atherosclerosis.Front Pharmacol. 2023 Mar 24;14:1144878. doi: 10.3389/fphar.2023.1144878. eCollection 2023. Front Pharmacol. 2023. PMID: 37033663 Free PMC article. Review.
-
Catechin Bioavailability Following Consumption of a Green Tea Extract Confection Is Reduced in Obese Persons without Affecting Gut Microbial-Derived Valerolactones.Antioxidants (Basel). 2022 Dec 18;11(12):2490. doi: 10.3390/antiox11122490. Antioxidants (Basel). 2022. PMID: 36552698 Free PMC article.
-
Green tea extract-associated acute liver injury: Case report and review.Clin Liver Dis (Hoboken). 2022 Dec 12;20(6):181-187. doi: 10.1002/cld.1254. eCollection 2022 Dec. Clin Liver Dis (Hoboken). 2022. PMID: 36523867 Free PMC article. Review.
-
Catechins as a Potential Dietary Supplementation in Prevention of Comorbidities Linked with Down Syndrome.Nutrients. 2022 May 12;14(10):2039. doi: 10.3390/nu14102039. Nutrients. 2022. PMID: 35631180 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous